List of Tables
Table 1. Global Antisense Oligonucleotides Drugs for ATTR Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Antisense Oligonucleotides Drugs for ATTR Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Antisense Oligonucleotides Drugs for ATTR Market Competitive Situation by Manufacturers in 2025
Table 4. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Antisense Oligonucleotides Drugs for ATTR Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Antisense Oligonucleotides Drugs for ATTR Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Antisense Oligonucleotides Drugs for ATTR, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Product Types and Applications
Table 12. Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antisense Oligonucleotides Drugs for ATTR Companies by Tier (Tier 1, Tier 2, Tier 3), based on Antisense Oligonucleotides Drugs for ATTR Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antisense Oligonucleotides Drugs for ATTR Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Antisense Oligonucleotides Drugs for ATTR Sales by Region (K Units), 2021–2026
Table 18. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Region (2021–2026)
Table 19. Global Antisense Oligonucleotides Drugs for ATTR Sales by Region (K Units), 2027–2032
Table 20. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Region (2027–2032)
Table 21. Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region (US$ Million), 2021–2026
Table 22. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Region (2021–2026)
Table 23. Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region (US$ Million), 2027–2032
Table 24. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Region (2027–2032)
Table 25. North America Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2021–2026
Table 27. North America Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2027–2032
Table 28. North America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2021–2026
Table 29. North America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2021–2026
Table 32. Europe Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2027–2032
Table 33. Europe Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2021–2026
Table 42. Latin America Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2027–2032
Table 43. Latin America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2027–2032
Table 50. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Type (2021–2026)
Table 51. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Type (2027–2032)
Table 52. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Type (2021–2026)
Table 53. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Type (2027–2032)
Table 54. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Type (2021–2026)
Table 57. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Type (2027–2032)
Table 58. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Type (2021–2026)
Table 59. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Type (2027–2032)
Table 60. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Application (2021–2026)
Table 61. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Application (2027–2032)
Table 62. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Application (2021–2026)
Table 63. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Application (2027–2032)
Table 64. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Application (2021–2026)
Table 67. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Application (2027–2032)
Table 68. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Application (2021–2026)
Table 69. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Application (2027–2032)
Table 70. Akcea Therapeutics Company Information
Table 71. Akcea Therapeutics Description and Business Overview
Table 72. Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Product
Table 74. Akcea Therapeutics Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Antisense Oligonucleotides Drugs for ATTR Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. AstraZeneca Antisense Oligonucleotides Drugs for ATTR Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Ionis Pharmaceuticals Company Information
Table 81. Ionis Pharmaceuticals Description and Business Overview
Table 82. Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Product
Table 84. Ionis Pharmaceuticals Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Antisense Oligonucleotides Drugs for ATTR Distributors List
Table 88. Antisense Oligonucleotides Drugs for ATTR Customers List
Table 89. Antisense Oligonucleotides Drugs for ATTR Market Trends
Table 90. Antisense Oligonucleotides Drugs for ATTR Market Drivers
Table 91. Antisense Oligonucleotides Drugs for ATTR Market Challenges
Table 92. Antisense Oligonucleotides Drugs for ATTR Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antisense Oligonucleotides Drugs for ATTR
Figure 2. Global Antisense Oligonucleotides Drugs for ATTR Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Antisense Oligonucleotides Drugs for ATTR Market Share by Type: 2025 & 2032
Figure 4. Inotersen Product Picture
Figure 5. Eplontersen Product Picture
Figure 6. Other Product Picture
Figure 7. Global Antisense Oligonucleotides Drugs for ATTR Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Antisense Oligonucleotides Drugs for ATTR Market Share by Application: 2025 & 2032
Figure 9. Hospital and Clinic
Figure 10. Retail Pharmacies
Figure 11. Other
Figure 12. Global Antisense Oligonucleotides Drugs for ATTR Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Antisense Oligonucleotides Drugs for ATTR Market Size (US$ Million), 2021–2032
Figure 14. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units), 2021–2032
Figure 15. Global Antisense Oligonucleotides Drugs for ATTR Average Price (US$/Unit), 2021–2032
Figure 16. Antisense Oligonucleotides Drugs for ATTR Report Years Considered
Figure 17. Antisense Oligonucleotides Drugs for ATTR Sales Share by Manufacturers in 2025
Figure 18. Global Antisense Oligonucleotides Drugs for ATTR Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Antisense Oligonucleotides Drugs for ATTR Players: Market Share by Revenue in Antisense Oligonucleotides Drugs for ATTR in 2025
Figure 20. Antisense Oligonucleotides Drugs for ATTR Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Antisense Oligonucleotides Drugs for ATTR Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2021–2032)
Figure 23. North America Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2021–2032)
Figure 24. United States Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2021–2032)
Figure 27. Europe Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2021–2032)
Figure 28. Germany Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Region (2021–2032)
Figure 35. China Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2021–2032)
Figure 43. Latin America Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Antisense Oligonucleotides Drugs for ATTR by Type (2021–2032)
Figure 54. Global Revenue Market Share of Antisense Oligonucleotides Drugs for ATTR by Type (2021–2032)
Figure 55. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Antisense Oligonucleotides Drugs for ATTR by Application (2021–2032)
Figure 57. Global Revenue Market Share of Antisense Oligonucleotides Drugs for ATTR by Application (2021–2032)
Figure 58. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Application (2021–2032)
Figure 59. Antisense Oligonucleotides Drugs for ATTR Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
